Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

ER-Stress-Induced Suppression of HLA-E on Bortezomib-Evading Malignant Plasma Cells Dramatically Enhances Their Susceptibility to NK Cell Killing: Identification of an Achilles Heel in Myeloma Cells That Can be Utilized to Prevent Disease Relapse Following Bortezomib Treatment

Mattias Carlsten, MD, PhD, Ali Namazi, MD, Robert N. Reger, B.S., Maria Berg, Richard W. Childs, MD

Blood (2015) 126 (23): 4296.

https://doi.org/10.1182/blood.V126.23.4296.4296

Published: 2015

Journal Articles

Treatment of Ex Vivo Expanded NK Cells with Daratumumab F(ab')2 Fragments Protects Adoptively Transferred NK Cells from Daratumumab-Mediated Killing and Augments Daratumumab-Induced Antibody Dependent Cellular Toxicity (ADCC) of Myeloma

Elena Cherkasova, PhD, Luis Espinoza, MD PhD, Ritesh Kotecha, Robert N. Reger, B.S., Maria Berg, Georg Aue, Ricardo M. Attar, PhD, A Kate Sasser, Mattias Carlsten, MD, PhD, Richard W. Childs, MD

Blood (2015) 126 (23): 4244.

https://doi.org/10.1182/blood.V126.23.4244.4244

Published: 2015

Journal Articles

Clinical-Grade mRNA Electroporation of NK Cells: A Novel and Highly Efficient Method to Genetically Reprogram Human NK Cells for Cancer Immunotherapy

Mattias Carlsten, MD PhD, Linhong Li, Su Su, MD PhD, Maria Berg, Robert Reger, Madhusudan V. Peshwa, Richard Childs, MD

Blood (2014) 124 (21): 2153.

https://doi.org/10.1182/blood.V124.21.2153.2153

Published: 2014

Journal Articles

Rhesus Macaque NK Cells Expanded Ex Vivo Undergo Similar Phenotypic and Functional Changes Observed With Expanded Human NK Cells Providing An Excellent Model To Optimize Adoptive NK Cell Transfer

Jan K. Davidson-Moncada, MD, PhD, Richard Childs, MD, Cynthia E. Dunbar, MD, Robert Reger, Ritesh Kotecha, Maria Berg, Chuanfeng Wu, PhD

Blood (2013) 122 (21): 2028.

https://doi.org/10.1182/blood.V122.21.2028.2028

Published: 2013

Journal Articles

Forced Fucosylation With ASC-101 Enhances The Binding Of Ex Vivo Expanded Human NK Cells To E-Selectin: A Novel Method To Improve The Homing Of Adoptively Transferred NK Cells To The Bone Marrow In Patients With Hematological Malignancies

Toshihiro Onishi, MD, Maria Berg, Robert Reger, Leonard Miller, PhD, Steve Wolpe, Lynnet Koh, MS, MBA, Richard Childs, MD

Blood (2013) 122 (21): 4499.

https://doi.org/10.1182/blood.V122.21.4499.4499

Published: 2013

Journal Articles

Improved Homing To Bone Marrow, Spleen and Lung Of Adoptively Infused NK Cells Expanded Ex Vivo With The Small Molecule Nicotinamide Using Feeder-Free Conditions

Gabi M. Frei, Maria Berg, Tony Peled, MSc, Robert N. Reger, Ritesh Kotecha, Toshihiro Onishi, MD, Luis Espinoza-Calderon, Nurit Persi, Chana Lador, Amnon Peled, Richard W. Childs, MD

Blood (2013) 122 (21): 897.

https://doi.org/10.1182/blood.V122.21.897.897

Published: 2013

Journal Articles

Nicotinamide (NAM) Increases Surface Expression of CD62L On in Vitro Expanded NK Cells

Ewelina K. Mamcarz, MD, Maria Berg, Tony Peled, Gabi M Frei, Robert Reger, Xin Tian, Ph.D., Richard Childs, MD

Blood (2012) 120 (21): 4355.

https://doi.org/10.1182/blood.V120.21.4355.4355

Published: 2012

Journal Articles

Co-Infusion of Allogeneic Cord Blood with Haploidentical CD34+ Cells Improved Transplant Outcome for Patients with Severe Aplastic Anemia Undergoing Cord Blood Transplantation

Blood (2011) 118 (21): 654.

https://doi.org/10.1182/blood.V118.21.654.654

Published: 2011

Journal Articles

A Phase I Trial of Adoptively Transferred Ex-Vivo Expanded Autologous Natural Killer (NK) Cells Following Treatment with Bortezomib to Sensitize Tumors to NK Cell Cytotoxicity

Robert N Reger, Maria Berg, Andreas Lundqvist, PhD, Theresa Donohue, MHS, PA-C, Mattias Carlsten, MD Ph.D, Dawn M Betters, Ph.D, Lisa Cook, RN, BSN, Catalina Ramos, RN, BSN, Sophia Grasmeder, RN, BSN, OCN, Su Su, MD, PhD, David Stroncek, MD, Jeremy Pantin, MD, Keyvan Keyvanfar, BS, Cristian A. Carvallo, MD, Hahn Khuu, MD, Richard Childs, MD

Blood (2011) 118 (21): 1001.

https://doi.org/10.1182/blood.V118.21.1001.1001

Published: 2011

Journal Articles

Killing of Quiescent and Cycling Chronic Myeloid Leukemia CD34+ Cells by Autologous Ex-Vivo Expanded Natural Killer Cells Is Enhanced by Bortezomib Treatment.

Agnes S.M. Yong, MD, PhD, Nicole Stephens, BS, Keyvan Keyvanfar, BS, Bipin N. Savani, MD, Rhoda Eniafe, BS, Maria Berg, BS, Elaine M. Sloand, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2010) 116 (21): 3395.

https://doi.org/10.1182/blood.V116.21.3395.3395

Published: 2010

Journal Articles

siRNA Inactivation of the Inhibitory Receptor NKG2A Augments the Anti-Tumor Effects of Adoptively Transferred NK Cells In Tumor-Bearing Hosts

Elissa Furutani, Su Su, MD, PhD, Aleah Smith, Maria Berg, Richard Childs, MD

Blood (2010) 116 (21): 1015.

https://doi.org/10.1182/blood.V116.21.1015.1015

Published: 2010

Journal Articles

In Vitro Assessment of Tolerance and Rejection Occurring After Co-Transplantation of Allogeneic Umbilical Cord Blood and Haploidentical CD34+ Cells as Treatment for Severe Aplastic Anemia

Nicole J. Gormley, MD, Aleah Smith, Maria Berg, Lisa Cook, RN, BSN, Catalina Ramos, RN, Sophia Grasmeder, RN, BSN, OCN, Theresa Donohue, MHS, PA-C, Richard Childs, MD

Blood (2010) 116 (21): 2352.

https://doi.org/10.1182/blood.V116.21.2352.2352

Published: 2010

Journal Articles

Adoptive Transfer of Escalating Doses of Ex Vivo Expanded Autologous Natural Killer (NK) Cells In Patients with Advanced Malignancies Following Bortezomib Treatment to Sensitize to NK-TRAIL Cytotoxicity

Aleah Smith, Hahn Khuu, MD, Dawn M Betters, RN, Lisa Cook, RN, BSN, Catalina Ramos, RN, BSN, Sophia Grasmeder, RN, BSN, OCN, Maria Berg, Rebecca Lopez, PhD, Su Su, MD, PhD, Vicki Fellowes, MT, David Stroncek, MD, Jeremy Pantin, MD, Sumi Vasu, MD, Theresa Donohue, MHS, PA-C, Keyvan Keyvanfar, BS, Richard Childs, MD

Blood (2010) 116 (21): 4296.

https://doi.org/10.1182/blood.V116.21.4296.4296

Published: 2010

Journal Articles

In Vitro Expanded NK Cells Have Increased Natural Cytotoxity Receptors, TRAIL and NKG2D Expression, and Superior Tumor Cytotoxicity Compared to Short-Term IL-2 –Activated NK Cells.

Maria Berg, Andreas Lundqvist, Dawn Betters, Richard W. Childs, MD

Blood (2009) 114 (22): 463.

https://doi.org/10.1182/blood.V114.22.463.463

Published: 2009

Journal Articles

Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells

Andreas Lundqvist, Hisayuki Yokoyama, Aleah Smith, Maria Berg, Richard Childs

Blood (2009) 113 (24): 6120–6127.

https://doi.org/10.1182/blood-2008-11-190421

Published: 2009

Journal Articles

Primitive quiescent CD34 + cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib

Agnes S. M. Yong, Keyvan Keyvanfar, Nancy Hensel, Rhoda Eniafe, Bipin N. Savani, Maria Berg, Andreas Lundqvist, Sharon Adams, Elaine M. Sloand, John M. Goldman, Richard Childs, A. John Barrett

Blood (2009) 113 (4): 875–882.

https://doi.org/10.1182/blood-2008-05-158253

Published: 2009

Journal Articles

Adoptively-Infused NK Cells Maintain Their Antitumor Effects in Vivo in the Presence of CyclosporineA (CSA)

Hisayuki Yokoyama, Andreas Lundqvist, Maria Berg, Muthalagu Ramanathan, Rebecca Lopez, Aleah Smith, Nicole Gormley, Su Su, J. Phillip McCoy, Richard W. Childs, MD

Blood (2008) 112 (11): 2563.

https://doi.org/10.1182/blood.V112.11.2563.2563

Published: 2008

Journal Articles

A Highly Efficient Method to Expand CD3 - CD56 + NK Cells from Cord Blood Segments

Sumithira Vasu, Maria Berg, Andreas Lundqvist, Muthalagu Ramanathan, Rebecca Lopez, Phil McCoy, Jr, Hua Zhang, Crystal Mackall, Richard Childs

Blood (2008) 112 (11): 3902.

https://doi.org/10.1182/blood.V112.11.3902.3902

Published: 2008

Journal Articles

A Rhesus Macaque Model to Optimize Adoptive NK Cell Therapy

Rebecca Lopez, Andreas Lundqvist, Stephanie Sellers, Maria Berg, Muthalagu Ramanathan, Sumithira Vasu, Aleah Smith, Cynthia E. Dunbar, Richard W. Childs, MD

Blood (2008) 112 (11): 3905.

https://doi.org/10.1182/blood.V112.11.3905.3905

Published: 2008

Journal Articles

Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies

Muthalagu Ramanathan, Su Su, Andreas Lundqvist, Maria Berg, Aleah Smith, Rebecca Lopez, Ann Williams, Erkut Bahceci, J. Philip McCoy, Laurent Boissel, Hans-Georg Klingemann, Richard Childs

Blood (2008) 112 (11): 3540.

https://doi.org/10.1182/blood.V112.11.3540.3540

Published: 2008

NARROW

ER-Stress-Induced Suppression of HLA-E on Bortezomib-Evading Malignant Plasma Cells Dramatically Enhances Their Susceptibility to NK Cell Killing: Identification of an Achilles Heel in Myeloma Cells That Can be Utilized to Prevent Disease Relapse Following Bortezomib Treatment

Treatment of Ex Vivo Expanded NK Cells with Daratumumab F(ab')2 Fragments Protects Adoptively Transferred NK Cells from Daratumumab-Mediated Killing and Augments Daratumumab-Induced Antibody Dependent Cellular Toxicity (ADCC) of Myeloma

Clinical-Grade mRNA Electroporation of NK Cells: A Novel and Highly Efficient Method to Genetically Reprogram Human NK Cells for Cancer Immunotherapy

Rhesus Macaque NK Cells Expanded Ex Vivo Undergo Similar Phenotypic and Functional Changes Observed With Expanded Human NK Cells Providing An Excellent Model To Optimize Adoptive NK Cell Transfer

Forced Fucosylation With ASC-101 Enhances The Binding Of Ex Vivo Expanded Human NK Cells To E-Selectin: A Novel Method To Improve The Homing Of Adoptively Transferred NK Cells To The Bone Marrow In Patients With Hematological Malignancies

Improved Homing To Bone Marrow, Spleen and Lung Of Adoptively Infused NK Cells Expanded Ex Vivo With The Small Molecule Nicotinamide Using Feeder-Free Conditions

Nicotinamide (NAM) Increases Surface Expression of CD62L On in Vitro Expanded NK Cells

Co-Infusion of Allogeneic Cord Blood with Haploidentical CD34+ Cells Improved Transplant Outcome for Patients with Severe Aplastic Anemia Undergoing Cord Blood Transplantation

A Phase I Trial of Adoptively Transferred Ex-Vivo Expanded Autologous Natural Killer (NK) Cells Following Treatment with Bortezomib to Sensitize Tumors to NK Cell Cytotoxicity

Killing of Quiescent and Cycling Chronic Myeloid Leukemia CD34+ Cells by Autologous Ex-Vivo Expanded Natural Killer Cells Is Enhanced by Bortezomib Treatment.

siRNA Inactivation of the Inhibitory Receptor NKG2A Augments the Anti-Tumor Effects of Adoptively Transferred NK Cells In Tumor-Bearing Hosts

In Vitro Assessment of Tolerance and Rejection Occurring After Co-Transplantation of Allogeneic Umbilical Cord Blood and Haploidentical CD34+ Cells as Treatment for Severe Aplastic Anemia

Adoptive Transfer of Escalating Doses of Ex Vivo Expanded Autologous Natural Killer (NK) Cells In Patients with Advanced Malignancies Following Bortezomib Treatment to Sensitize to NK-TRAIL Cytotoxicity

In Vitro Expanded NK Cells Have Increased Natural Cytotoxity Receptors, TRAIL and NKG2D Expression, and Superior Tumor Cytotoxicity Compared to Short-Term IL-2 –Activated NK Cells.

Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells

Primitive quiescent CD34 + cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib

Adoptively-Infused NK Cells Maintain Their Antitumor Effects in Vivo in the Presence of CyclosporineA (CSA)

A Highly Efficient Method to Expand CD3 - CD56 + NK Cells from Cord Blood Segments

A Rhesus Macaque Model to Optimize Adoptive NK Cell Therapy

Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only